Abeona Therapeutics Inc. (ABEO)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Vishwas Seshadri M.B.A., Ph.D.
|
President, CEO & Director | 1.52M | -- | 1976 |
|
Mr. Joseph Walter Vazzano CPA
|
Chief Financial Officer | 898.47k | -- | 1984 |
|
Dr. Brendan M. O'Malley J.D., Ph.D.
|
Chief Legal Officer | 783.93k | -- | 1969 |
|
Mr. Brian Kevany Ph.D.
|
Chief Technical & Scientific Officer | -- | -- | -- |
|
Mr. Gregory Gin
|
Vice President of Investor Relations & Corporate Communications | -- | -- | -- |
|
Ms. Gianine Esposito
|
Senior VP & Chief People Officer | -- | -- | -- |
|
Mr. Jon Voss
|
VP & Head of Quality | -- | -- | 1960 |
|
Dr. Madhav Vasanthavada M.B.A., Ph.D.
|
SVP, Chief Commercial Officer & Head of Business Development | -- | -- | 1979 |
|
Mr. Carl Denny
|
Senior Vice President of Regulatory Affairs | -- | -- | -- |
|
Ms. Megan Callan
|
Vice President & Head of Quality | -- | -- | -- |
Abeona Therapeutics Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 226
Description
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Corporate Governance
Upcoming Events
November 11, 2026 at 1:30 PM UTC
Abeona Therapeutics Inc. Earnings Date
